- Datum06.11.2024
- Uhrzeit15:00 - 15:30 Uhr
- Veranstalterstock3
Dr Reddy's Laboratories Ltd. Reg. Shares (Sp.ADRs)/1 IR 5 Chart
Du willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnenDr Reddy's Laboratories Ltd. Reg. Shares (Sp.ADRs)/1 IR 5 Realtime-Kurs
Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
---|---|---|---|---|---|---|
L&S | VK | |||||
Stuttgart | VK | |||||
Baader | VK |
Passende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Wertentwicklung (NYSE)
Wikifolio
Passender Service zu Dr Reddy's Laboratories Ltd. Reg. Shares (Sp.ADRs)/1 IR 5
Webinar zu Dr Reddy's Laboratories Ltd. Reg. Shares (Sp.ADRs)/1 IR 5
Kursinformationen (NYSE)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)12,744-73,990
- Jahrestief / Hoch ($)13,432-16,892
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Dr Reddy's Laboratories Ltd. Reg. Shares (Sp.ADRs)/1 IR 5
Termine von Dr Reddy's Laboratories Ltd. Reg. Shares (Sp.ADRs)/1 IR 5
Beschreibung
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.